All Comments by Sanjay Pimplikar
- Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
- FDA Invites Comment on Drug Testing Guidance for Early AD
- Does ApoE4 Lower Brain Metabolism Independently of Aβ?
- CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate
- Enter the New Alzheimer’s Gene: TREM2 Variant Triples Risk
- The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.
- In Cells, Late- and Early Onset Alzheimer’s Look Different
- Protective APP Mutation Found—Supports Amyloid Hypothesis
- Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.
- NIH Director Announces $100M Prevention Trial of Genentech Antibody
- Biomarker Duo Signals Mental Decline
- Antioxidants No Help for Alzheimer’s, Biomarker Trial Says
- Testing the right target and right drug at the right stage.
- Aggressive Diabetes Treatment Slows Atrophy But Not Mental Slide
- In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function.